Browsing byAuthor문영철

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 98 to 127 of 186

Issue DateTitleAuthor(s)Type
2022Management of immune thrombocytopenia: 2022 update of Korean experts recommendations문영철; 박영훈Review
2017Management of immune thrombocytopenia: Korean experts recommendation in 2017문영철Review
2015Manipulation of beta-catenin pathway to overcome endocrine resistance in breast cancer.이순남; 성주명; 이경은; 문영철; 남은미Meeting Abstract
2011Matched-Pair Analysis Comparing Outcomes of Second Autologous Stem Cell Transplantation and Chemotherapy As a Salvage Therapy in Patients with Multiple Myeloma Who Relapsed After Front-Line Autologous Stem Cell Transplantation문영철Meeting Abstract
2013Matched-pair analysis to compare the outcomes of a second salvage auto-SCT to systemic chemotherapy alone in patients with multiple myeloma who relapsed after front-line auto-SCT문영철Article
2016MITOCHONDRIAL SPECIFIC ROS HYPEROXIDATION VIA PEROXIREDOXIN III HAS IMPORTANT ROLES ON ARSENIC TRIOXIDE INDUCED APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA이순남; 성주명; 유은선; 이경은; 문영철; 남은미; 우현애Meeting Abstract
2011Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)문영철Article
2018Multicenter retrospective analysis of clinical characteristics, treatment patterns, and outcomes in very elderly patients with diffuse large B-cell lymphoma: The Korean cancer study group LY16-01문영철Article
2015MUTATION ANALYSIS OF JAK2, MPL, CALR, ASXL1, TET2, IDH1, IDH2, DNMT3A, AND SF3B1 IN MYELOPROLIFERATIVE NEOPLASM문영철Meeting Abstract
2010Myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura정화순; 성주명; 허정원; 문영철Article
2011Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study문영철Meeting Abstract
2015Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia문영철Article
2017Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia허정원; 문영철; 정혜선; 정태동Article
2023Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)문영철Article
2022Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909)문영철Article
2020Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia문영철Article
2007Outgrowing endothelial cells that are derived from human umbilical cord blood improve neovascularization in hind-limb ischemia.성주명; 유은선; 권기환; 이경은; 문영철Meeting Abstract
2020Peroxiredoxin 3 has important roles on arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line via hyperoxidation of mitochondrial specific reactive oxygen species성주명; 유은선; 허정원; 이경은; 문영철; 남은미; 우현애Article
2017PEROXIREDOXIN II ACTIVITY HAS IMPORTANT ROLES TO CONTROL ABL TYROSINE KINASE ACTIVITY IN STIS TREATED CML PATIENTS AND ITS POTENTIAL APPLICATION IN IMATINIB RESISTANCE문영철Meeting Abstract
2018Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)문영철Article
2017Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia문영철Article
2022Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma이경은; 문영철Article
2011Polymorphisms of ERCC1 and ERCC5 genotypes were associated with response to imatinib therapy in chronic phase chronic myeloid leukemia공지현Doctoral Thesis
2012Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia문영철Article
2020Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)문영철Article
2005Potential usefulness of leukotriene B4 (LTB4) on mobilization of hematopoietic progenitor cells (HPC)성주명; 문영철Meeting Abstract
2005Predictable prognostic factor of CD56 expression in acute myeloid leukemia with t(8 : 21) including allogeneic hematopoietic stem cell transplantation성주명; 문영철Meeting Abstract
2007Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation성주명; 문영철Article
2013Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib문영철Article
2015PREDICTIVE FACTORS FOR TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH IMATINIB-TREATED, UNDETECTABLE MOLECULAR RESIDUAL DISEASE: RESULTS FROM THE KID STUDY문영철Meeting Abstract

BROWSE